TUCSON, Ariz., Oct. 13 /PRNewswire-FirstCall/ -- Ventana Medical Systems, Inc. , today announced it will hold a conference call on Friday, October 20, 2006, at 10:00 a.m. Eastern time to discuss its third quarter financial and operating results. The call can be accessed via the Internet both live and as a replay at http://phx.corporate-ir.net/phoenix.zhtml?p=irol- eventDetails&c=79080&eventID=1400465.
Ventana develops, manufactures, and markets instrument/reagent systems that automate slide preparation and staining in clinical histology and drug discovery laboratories worldwide. Ventana’s clinical systems are important tools used in the diagnosis and treatment of cancer and infectious diseases. Ventana’s drug discovery systems are used to accelerate the discovery of new drug targets and evaluate the safety of new drug compounds.
Visit the Ventana Medical Systems, Inc., website at www.ventanamed.com.
Ventana Medical Systems, Inc.
CONTACT: Christopher M. Gleeson, President and CEO, +1-520-229-3787, orNick Malden, Chief Financial Officer, +1-520-229-3857, both of VentanaMedical Systems, Inc.
Web site: http://www.ventanamed.com//
